JPH11180833A - Composition for scalp and hair - Google Patents
Composition for scalp and hairInfo
- Publication number
- JPH11180833A JPH11180833A JP36340197A JP36340197A JPH11180833A JP H11180833 A JPH11180833 A JP H11180833A JP 36340197 A JP36340197 A JP 36340197A JP 36340197 A JP36340197 A JP 36340197A JP H11180833 A JPH11180833 A JP H11180833A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- composition
- scalp
- hyaluronic acid
- acetylated hyaluronic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000004761 scalp Anatomy 0.000 title claims abstract description 48
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 210000004209 hair Anatomy 0.000 title claims description 42
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 21
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 21
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 21
- 210000003780 hair follicle Anatomy 0.000 claims abstract description 15
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 claims abstract description 12
- 239000012190 activator Substances 0.000 claims abstract description 9
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 4
- 150000001340 alkali metals Chemical class 0.000 claims abstract description 4
- 238000006467 substitution reaction Methods 0.000 claims abstract description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 claims description 10
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 6
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 claims description 5
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 229930007845 β-thujaplicin Natural products 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- -1 nicotinamide, vitamin Chemical class 0.000 claims description 3
- 229940055726 pantothenic acid Drugs 0.000 claims description 3
- 235000019161 pantothenic acid Nutrition 0.000 claims description 3
- 239000011713 pantothenic acid Substances 0.000 claims description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 claims 3
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims 1
- 229940106681 chloroacetic acid Drugs 0.000 claims 1
- 229940043279 diisopropylamine Drugs 0.000 claims 1
- 208000001840 Dandruff Diseases 0.000 abstract description 18
- 230000003405 preventing effect Effects 0.000 abstract description 10
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract description 8
- 239000002304 perfume Substances 0.000 abstract description 5
- 235000005152 nicotinamide Nutrition 0.000 abstract description 4
- 239000011570 nicotinamide Substances 0.000 abstract description 4
- 239000002904 solvent Substances 0.000 abstract description 3
- 239000004094 surface-active agent Substances 0.000 abstract description 2
- 239000002562 thickening agent Substances 0.000 abstract description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 238000004040 coloring Methods 0.000 abstract 1
- 230000035617 depilation Effects 0.000 abstract 1
- 239000003906 humectant Substances 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- 230000000694 effects Effects 0.000 description 24
- 201000004384 Alopecia Diseases 0.000 description 18
- 230000003676 hair loss Effects 0.000 description 16
- 208000024963 hair loss Diseases 0.000 description 13
- 239000006210 lotion Substances 0.000 description 8
- 230000003658 preventing hair loss Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000008213 purified water Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000003676 hair preparation Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- ZTLBKEBOAKWETD-UHFFFAOYSA-N [Na].[N+](=O)([O-])C1=C(C(=CC=C1)OC)O Chemical compound [Na].[N+](=O)([O-])C1=C(C(=CC=C1)OC)O ZTLBKEBOAKWETD-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical class CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940125697 hormonal agent Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000004037 social stress Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は頭皮頭髪用組成物に
関する。さらに詳しくは優れた脱毛防止効果及びフケ・
カユミ防止効果を有する頭皮頭髪用組成物に関する。TECHNICAL FIELD The present invention relates to a composition for scalp hair. More specifically, it has an excellent hair loss prevention effect and dandruff
The present invention relates to a scalp hair composition having a Kayumi prevention effect.
【0002】[0002]
【従来の技術】頭皮頭髪用組成物には様々な種類があ
り、様々な頭皮頭髪状態に対応した製品が毛髪化粧料、
育毛剤等として開発されている。例えば、頭皮における
フケやカユミを防止することにより脱毛を防止する製品
が開発されている。2. Description of the Related Art There are various types of scalp hair compositions, and products corresponding to various scalp hair conditions are hair cosmetics,
It has been developed as a hair restorer and the like. For example, products have been developed that prevent hair loss by preventing dandruff and Kayumi on the scalp.
【0003】頭皮における様々なトラブルは、高齢化社
会を迎えた今日では社会的ストレスの増大も伴って増加
しつつあり、頭皮におけるトラブルに対応した頭皮頭髪
化粧料の需要は急増している。[0003] In today's aging society, various troubles on the scalp are increasing along with an increase in social stress, and the demand for scalp hair cosmetics corresponding to troubles on the scalp is rapidly increasing.
【0004】一般に、頭部の禿や脱毛、毛の細り、頭皮
のフケやカユミ等の原因としては、毛根の皮脂腺等の器
官における男性ホルモンの活性化、過剰な皮脂分泌、過
酸化脂質の生成、毛包への血流量の低下及びストレス等
が挙げられる。In general, baldness and alopecia of the head, thinning of hair, dandruff and kayumi of the scalp are caused by activation of androgens in organs such as sebaceous glands of hair root, excessive sebum secretion, and production of lipid peroxide. And a decrease in blood flow to the hair follicle and stress.
【0005】また、丈夫で美しい髪を育てるうえで、十
分な毛包への栄養補給が出来ない場合、細毛ややせ毛の
原因となる。また、毛包への血流量の低下は、栄養不足
や老廃物の排泄の機能の低下を招く結果となる。[0005] In addition, when sufficient nutrition is not supplied to hair follicles for growing durable and beautiful hair, fine hair and thin hair may be caused. Also, a decrease in blood flow to the hair follicle results in a lack of nutrition and a reduced function of excreting waste products.
【0006】このような観点から、頭皮における角質層
のターンオーバーや過剰な皮脂分泌等を改善すること
は、少なくとも頭皮における血流機能の低下を改善する
ことと共に、頭皮及び頭髪のトラブルを解決する上で欠
かせないポイントとなる。[0006] From such a point of view, improving turnover of the stratum corneum and excessive sebum secretion in the scalp solves at least a decrease in blood flow function in the scalp and solves problems in the scalp and hair. It is an indispensable point on the top.
【0007】従来の頭皮頭髪用組成物は一般に、これら
の禿や脱毛の原因と考えられる要素を取り除いたり軽減
する作用を持つ物質を配合したものである。例えば、ビ
タミンB、ビタミンE等のビタミン類、セリン、メチオ
ニン等のアミノ酸類、センブリエキス、アセチルコリン
誘導体などの血管拡張剤、紫根エキス等の抗炎症剤、エ
ストラジオール等の女性用ホルモン剤、セファランチン
などの皮膚機能亢進剤等が配合され、禿や脱毛、髪の細
りの予防および治療に用いられている。[0007] Conventional scalp hair compositions generally contain a substance having an action of removing or reducing the factors considered to be the cause of baldness and hair loss. For example, vitamins such as vitamin B and vitamin E, amino acids such as serine and methionine, assembly extracts, vasodilators such as acetylcholine derivatives, anti-inflammatory agents such as purple root extract, hormonal agents for women such as estradiol, cepharanthin and the like It contains a skin function enhancer and the like, and is used for preventing and treating baldness, hair loss, and hair thinning.
【0008】[0008]
【発明が解決しようとする課題】しかしながら、これら
に成分を少量のみ頭皮頭髪用組成物中に配合しても十分
な効果を得ることは難しく、逆に多く配合すると使用部
分およびその周辺に深いな刺激感や発赤を伴う傾向が強
まるためその配合量には制限があり必ずしも所望の効果
が充分に得られないといった問題点があった。However, it is difficult to obtain a sufficient effect even if only a small amount of these components is incorporated into the scalp hair composition. Since the tendency to accompany irritation and redness increases, there is a problem that the compounding amount is limited and a desired effect cannot always be sufficiently obtained.
【0009】本発明者等は上述の観点に鑑み鋭意研究を
重ねた結果、アセチル化ヒアルロン酸と特定の毛包賦活
剤とを組み合わせて配合することにより、優れた脱毛防
止効果と頭皮のフケ・カユミ防止効果を有しかつ安全性
にも優れる頭皮頭髪用組成物が得られることを見出し本
発明を完成するに至った。The inventors of the present invention have conducted intensive studies in view of the above viewpoints. As a result, the combination of acetylated hyaluronic acid and a specific hair follicle activator has an excellent hair loss preventing effect and dandruff on the scalp. The present inventors have found that a composition for scalp hair which has a Kayumi prevention effect and is also excellent in safety has been obtained, and has completed the present invention.
【0010】本発明は優れた脱毛防止効果と頭皮のフケ
・カユミ防止効果を有しかつ安全性にも優れる頭皮頭髪
用組成物を提供することを目的とする。It is an object of the present invention to provide a composition for scalp hair which has an excellent effect of preventing hair loss and an effect of preventing dandruff and swelling of the scalp and is also excellent in safety.
【0011】[0011]
【課題を解決するための手段】すなわち、本発明は、ア
セチル化ヒアルロン酸と毛包賦活剤とを含有することを
特徴とする頭皮頭髪用組成物を提供するものである。That is, the present invention provides a scalp and hair composition comprising acetylated hyaluronic acid and a hair follicle activator.
【0012】また、本発明は、前記アセチル化ヒアルロ
ン酸のアセチル基の置換数が、下記化学式「化2」で表
される繰り返し構造単位において平均して2〜4である
ことを特徴とする前記の頭皮頭髪用組成物を提供するも
のである。Further, the present invention is characterized in that the acetylated hyaluronic acid has an average of 2 to 4 substitutions of an acetyl group in the repeating structural unit represented by the following chemical formula (Formula 2). And a composition for scalp hair.
【化2】 (式中、R1、R2、R3、R4は水素またはエステル結合
されたアセチル基を意味し、且つ平均して各繰り返し構
造においてR1〜R4の少なくとも2以上がアセチル基で
ある。R5は水素またはアルカリ金属原子を示す。)Embedded image (Wherein, R 1 , R 2 , R 3 , and R 4 each represent hydrogen or an acetyl group bonded through an ester bond, and on average, at least two or more of R 1 to R 4 in each repeating structure are acetyl groups. R 5 represents hydrogen or an alkali metal atom.)
【0013】さらに、本発明は、前記毛包賦活剤が、ニ
コチン酸アミド、ビタミンB6及びその誘導体、ビオチ
ン、パントテン酸及びその誘導体、セファランチン、モ
ノニトログアヤコール、モノニトログアヤコールナトリ
ウム、6−ベンジルアミノプリン、ジイソプロピルアミ
ンジクロル酢酸、ヒノキチオールからなる群から選ばれ
た一種または二種以上であることを特徴とする前記の頭
皮頭髪用組成物を提供するものである。Furthermore, the present invention, the hair follicle activating agent, nicotinic acid amide, vitamin of B 6 and derivatives thereof, biotin, pantothenic acid and its derivatives, cepharanthine, mononitroguayacol, mononitroguayacol sodium, 6-benzylaminopurine The composition for scalp hair is one or more selected from the group consisting of purine, diisopropylamine dichloroacetic acid, and hinokitiol.
【0014】また、本発明は、前記アセチル化ヒアルロ
ン酸の含有量が頭皮頭髪用組成物全量に対して0.00
1〜10重量%であることを特徴とする前記の頭皮頭髪
用組成物を提供するものである。[0014] The present invention also relates to the present invention, wherein the content of the acetylated hyaluronic acid is 0.00% to the total amount of the scalp hair composition.
1 to 10% by weight of the composition for scalp hair.
【0015】さらに、本発明は、前記毛包賦活剤の含有
量が頭皮頭髪用組成物全量に対して0.001〜5重量
%であることを特徴とする前記の頭皮頭髪用組成物を提
供するものである。Further, the present invention provides the composition for scalp hair, wherein the content of the hair follicle activator is 0.001 to 5% by weight based on the total amount of the composition for scalp hair. Is what you do.
【0016】[0016]
【発明の実施の形態】以下、本発明の構成について詳述
する。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The configuration of the present invention will be described below in detail.
【0017】本発明に用いるアセチル化ヒアルロン酸
は、ヒアルロン酸の水酸基を部分的にアセチル化した高
分子化合物であり、水酸基に対するアセチル化率は特に
限定されないが、下記一般式「化3」で表される繰り返
し構造単位においてアセチル基の置換数が平均して2〜
4のものが好ましい。The acetylated hyaluronic acid used in the present invention is a high molecular compound in which the hydroxyl group of hyaluronic acid is partially acetylated. The acetylation rate for the hydroxyl group is not particularly limited, but is represented by the following general formula [Chemical Formula 3]. The number of substitution of the acetyl group in the repeating structural unit is 2 to 2 on average
Four are preferred.
【化3】 (式中、R1、R2、R3、R4は水素またはエステル結合
されたアセチル基を意味し、且つ平均して各繰り返し構
造においてR1〜R4の少なくとも2以上がアセチル基で
ある。R5は水素またはアルカリ金属原子を示す。)Embedded image (Wherein, R 1 , R 2 , R 3 , and R 4 each represent hydrogen or an acetyl group bonded through an ester bond, and on average, at least two or more of R 1 to R 4 in each repeating structure are acetyl groups. R 5 represents hydrogen or an alkali metal atom.)
【0018】アセチル化ヒアルロン酸の製造方法は、例
えば、粉末状のヒアルロン酸を酢酸に分散し触媒として
無水トリフルオロ酢酸を加て反応させる方法や、酢酸に
分散しp−トルエンスルホン酸を加えさらに無水酢酸を
加えて反応させる方法、あるいは無水酢酸溶媒に懸濁さ
せ濃硫酸を加えて反応させる方法等が知られている(特
開平6−9707号公報、特開平8−53501号公報
参照)。The method for producing acetylated hyaluronic acid includes, for example, a method in which powdery hyaluronic acid is dispersed in acetic acid and reacted by adding trifluoroacetic anhydride as a catalyst, or a method in which p-toluenesulfonic acid is dispersed in acetic acid and p-toluenesulfonic acid is added. A method of reacting by adding acetic anhydride or a method of suspending in acetic anhydride solvent and adding concentrated sulfuric acid to react is known (see JP-A-6-9707 and JP-A-8-53501).
【0019】本発明に用いるアセチル化ヒアルロン酸の
配合量は、頭皮頭髪用組成物全量に対して、通常、0.
001〜10重量%、好ましくは0.01〜5重量%で
ある。0.001重量%未満では十分な脱毛防止や頭皮
のフケ・カユミ防止効果が得られず、また、10重量%
を超えると頭皮に不快なべたつき感を与える場合があ
る。The amount of acetylated hyaluronic acid to be used in the present invention is usually 0.1% based on the total amount of the composition for scalp and hair.
001 to 10% by weight, preferably 0.01 to 5% by weight. If the amount is less than 0.001% by weight, sufficient hair loss prevention effect and dandruff / kayumi prevention effect on the scalp cannot be obtained, and 10% by weight.
Exceeding the scalp may give an unpleasant sticky feeling.
【0020】本発明に用いる毛包賦活剤は、例えば、ニ
コチン酸アミド、ビタミンB6及びその誘導体、ビオチ
ン、パントテン酸及びその誘導体、セファランチン、モ
ノニトログアヤコール、モノニトログアヤコールナトリ
ウム、6−ベンジルアミノプリン、ジイソプロピルアミ
ンジクロル酢酸、ヒノキチオール等が挙げられ、本発明
においては、これらの一種または二種以上が好ましく用
いられる。The hair follicle activating agent used in the present invention include, for example, nicotinic acid amide, vitamin of B 6 and derivatives thereof, biotin, pantothenic acid and its derivatives, cepharanthine, mononitroguayacol, mononitroguayacol sodium, 6-benzylaminopurine , Diisopropylamine dichloroacetic acid, hinokitiol and the like, and in the present invention, one or more of these are preferably used.
【0021】本発明に用いる毛包賦活剤の配合量は、頭
皮頭髪用組成物全量に対して、通常、0.001〜5重
量%、好ましくは0.01〜3重量%である。0.00
1重量%未満では十分な脱毛防止や頭皮のフケ・カユミ
防止効果が得られず、また、5重量%を超えると製剤上
配合が困難になったり、頭皮に不快な刺激感を与える場
合があるので好ましくない。The amount of the hair follicle activator used in the present invention is usually 0.001 to 5% by weight, preferably 0.01 to 3% by weight, based on the total amount of the scalp hair composition. 0.00
If the amount is less than 1% by weight, sufficient hair loss prevention and scalp dandruff and Kayumi preventive effects cannot be obtained. If the amount is more than 5% by weight, it may be difficult to formulate the composition or may give an unpleasant irritant feeling to the scalp. It is not preferable.
【0022】本発明の頭皮頭髪用組成物は、上記した必
須成分の他に、本発明の効果を損なわない範囲で、通常
化粧料に用いられる他の成分、例えば、油分、界面活性
剤、保湿剤、増粘剤、紫外線吸収剤、酸化防止剤、防腐
剤、香料、色素、水、アルコール等の溶媒を必要に応じ
て適宜配合し目的とする剤形に応じて常法により製造す
ることができる。The composition for scalp and hair of the present invention contains, in addition to the above-mentioned essential components, other components usually used in cosmetics, such as oils, surfactants, and moisturizers, as long as the effects of the present invention are not impaired. It can be manufactured by a conventional method according to the desired dosage form by appropriately mixing a solvent such as an agent, a thickener, an ultraviolet absorber, an antioxidant, an antiseptic, a fragrance, a pigment, water, and an alcohol as needed. it can.
【0023】本発明の頭皮頭髪用組成物とは、化粧料、
医薬品、医薬部外品として頭皮または頭髪に適用する外
用剤で、その剤型は任意であり、例えば、液状、乳液、
軟膏、クリーム、ゲル、エアゾールなど外用に適用可能
な剤型のものであればいずれでもよく、例えば、トニッ
ク、スカルプトリートメント等の形態で用いられる。The composition for scalp hair of the present invention includes cosmetics,
Pharmaceutical, an external preparation applied to the scalp or hair as a quasi-drug, its dosage form is arbitrary, for example, liquid, emulsion,
Ointments, creams, gels, aerosols, and other dosage forms that can be applied externally may be used. For example, they are used in the form of tonics, scalp treatments, and the like.
【0024】[0024]
【実施例】次に、実施例を挙げて本発明を更に詳しく説
明するが本発明はこれらの実施例のみに限定されるもの
ではない。なお、以下の実施例において配合量は重量%
である。Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples. In addition, in the following examples, the compounding amount is% by weight.
It is.
【0025】「表1」及び「表2」に示す実施例及び比
較例について、以下の試験及び評価方法により脱毛効果
及びフケ・カユミ防止効果について検討した。その結果
を「表3」及び「表4」に示す。With respect to the examples and comparative examples shown in Tables 1 and 2, the hair removal effect and the dandruff / kayumi prevention effect were examined by the following tests and evaluation methods. The results are shown in “Table 3” and “Table 4”.
【0026】「脱毛防止効果試験」実施例及び比較例の
試料(ローション)使用前後の洗髪による脱毛本数の変
化を測定した。被験者は男性で、比較例および実施例各
群10名とした。試験期間は6ヶ月間とし、前期の2ヶ
月間は試料無塗布の期間、後期4ヶ月間を試料塗布期間
とした。試料塗布期間には、試料を1日2回、1回につ
き2〜4mlを頭皮に塗布した。試験期間中には、1日
おきに洗髪して抜け毛を回収し、1週間分をまとめてそ
の終毛の本数を数えた。抜け毛数の評価は、試料塗布期
間の洗髪1回あたりの抜け毛本数を用い、前期最終週平
均値と後期最終週平均値を比較した。この結果を以下の
基準により判定し、+以上の被験者割合が50%以上の
場合を有効とし、その他は無効として評価した。 (判定基準) ++:抜け毛本数が70本以上減少しており著しい効果
を認めた。 +:抜け毛本数が40本以上減少しておりかなり効果を
認めた。 ±:抜け毛本数が10本以上減少しておりやや効果を認
めた。 −:抜け毛本数が10本未満の減少または抜け毛数の増
加があり効果は認められなかった。"Test for the effect of preventing hair loss" The change in the number of hair loss due to hair washing before and after using the samples (lotions) of the examples and comparative examples was measured. The test subjects were male, and each of the comparative example and the example was 10 persons in each group. The test period was six months, the first two months were the period of no sample application, and the last four months were the sample application period. During the sample application period, 2 to 4 ml of the sample was applied to the scalp twice a day. During the test period, the hair was washed every other day to collect the hair loss, and the number of end hairs was counted for one week. The number of hair loss was evaluated by using the number of hair loss per hair washing during the sample application period, and the average value of the last week in the first half and the average value of the last week in the second half were compared. The results were judged according to the following criteria. A case where the proportion of subjects with + or more was 50% or more was evaluated as valid, and the others were evaluated as invalid. (Evaluation criteria) ++: The number of hair loss decreased by 70 or more, and a remarkable effect was recognized. +: The number of hair loss was reduced by 40 or more, and a considerable effect was recognized. ±: The number of hair loss was reduced by 10 or more, and a slight effect was recognized. -: The number of hair loss was less than 10 or the number of hair loss increased, and no effect was observed.
【0027】「フケ・カユミ防止効果試験」特にフケ・
カユミを訴える男性を対象とし、比較例および実施例各
群10名について試験終了後のフケ・カユミについて調
査し、フケ中のタンパク質量とカユミの程度によって評
価した。試料塗布期間は3ヶ月とし、この間薬剤無添加
のシャンプーで1日1回洗髪し、試料を1日2回、1回
につき2〜4mlを頭皮に塗布した。試験終了時に、被
験者より洗髪前に吸引装置により頭部フケを採取し、フ
ケ中のタンパク質量を測定してその平均値を平均フケ量
として評価した。また各被験者に対し頭皮のカユミにつ
いて調査し、その程度を以下の基準に従い判定しその平
均値で評価した。 (判定基準) 3:強いカユミがある。 2:カユミがある。 1:ややカユミがある。 0:カユミはない。"Test for the effect of preventing dandruff and Kayumi"
A group of 10 men in each of the comparative example and the example were investigated for dandruff / kayumi after the test, and evaluated based on the amount of protein in dandruff and the degree of kayumi. The sample application period was three months. During this period, the hair was washed once a day with a shampoo containing no drug, and the sample was applied twice a day to the scalp twice a day. At the end of the test, head dandruff was collected from the subject with a suction device before washing the hair, the amount of protein in the dandruff was measured, and the average value was evaluated as the average dandruff amount. In addition, each subject was examined for scalp Kayumi, the degree was determined according to the following criteria, and the average was evaluated. (Judgment criteria) 3: There is strong Kayumi. 2: There is Kayumi. 1: There is a little Kayumi. 0: There is no Kayumi.
【0028】[0028]
【表1】 [Table 1]
【表2】 [Table 2]
【0029】「製造方法」95%エタノールに、アセチ
ル化ヒアルロン酸、毛包賦活剤、グリセリン、POE硬
化ヒマシ油(100モル付加)、香料を溶解させた。次
に、精製水にリンゴ酸、色素を溶解させ、エタノール部
に加えた後、撹拌させ透明液状のローションを得た。[Production method] Acetylized hyaluronic acid, hair follicle activator, glycerin, POE hydrogenated castor oil (100 mol added) and perfume were dissolved in 95% ethanol. Next, malic acid and a dye were dissolved in purified water, added to the ethanol part, and stirred to obtain a transparent liquid lotion.
【0030】[0030]
【表3】 1[Table 3] 1
【表4】 [Table 4]
【0031】「表3」及び「表4」から明らかなように
本発明の実施例は脱毛防止効果に優れかつフケ・カユミ
防止効果に優れていた。As is clear from Tables 3 and 4, the examples of the present invention were excellent in the effect of preventing hair loss and the effect of preventing dandruff and kayumi.
【0032】以下に本発明のその他の実施例を示すが、
いずれの実施例も脱毛防止、フケ・カユミ防止効果及び
安全性に優れ、安定性にも優れるものであった。Hereinafter, other embodiments of the present invention will be described.
All of the examples were excellent in the effect of preventing hair loss, the effect of preventing dandruff and Kayumi, the safety, and the stability.
【0033】 「実施例12:ローション」 配合成分 重量% 95%エタノール 55.0 アセチル化ヒアルロン酸 5.0 ニコチン酸アミド 0.5 ヒノキチオール 0.2 1,3−ブチレングリコール 1.5 POE硬化ヒマシ油(60モル付加) 1.0 コハク酸 適量 香料および色素 適量 精製水 残分 製造方法:95%エタノールにアセチル化ヒアルロン酸
を溶解させ、ニコチン酸アミド、ヒノキチオール、1,
3−ブチレングリコール、POE硬化ヒマシ油(60モル
付加)、香料を溶解させた。次に、精製水にコハク酸、
色素を溶解させ、エタノール部に加えた後、撹拌させ透
明液状のローションを得た。Example 12: Lotion Ingredients Weight% 95% Ethanol 55.0 Acetylated Hyaluronic Acid 5.0 Nicotinamide 0.5 Hinokitiol 0.2 1,3-butylene glycol 1.5 POE hydrogenated castor oil (60 mol addition) 1.0 Succinic acid Appropriate amount Fragrance and pigment Appropriate amount Purified water residue Production method: Acetylated hyaluronic acid is dissolved in 95% ethanol, and nicotinamide, hinokitiol, 1,
3-butylene glycol, POE hydrogenated castor oil (60 mole addition) and perfume were dissolved. Next, succinic acid in purified water,
After dissolving the dye and adding it to the ethanol part, the mixture was stirred to obtain a transparent liquid lotion.
【0034】 「実施例13:ローション」 配合成分 重量% 95%エタノール 75.0 アセチル化ヒアルロン酸 0.3 パントテニルエチルエーテル 5.0 セファランチン 0.05 ジプロピレングリコール 1.0 POE(24モル)・POP(13モル)テ゛シルテトラテ゛シルエーテル 0.5 乳酸 適量 乳酸ナトリウム 適量 香料および色素 適量 精製水 残分 製造方法:95%エタノールにアセチル化ヒアルロン酸
を溶解させ、パントテニルエチルエーテル、セファラン
チン、ジプロピレングリコール、POE(24モル)・POP(13モル)
テ゛シルテトラテ゛シルエーテル、香料を溶解させた。次に、精製水に
乳酸、乳酸ナトリウム、色素を溶解させ、エタノール部
に加えた後、撹拌させ透明液状のローションを得た。“Example 13: Lotion” Ingredients Ingredients% by weight 95% Ethanol 75.0 Acetylated hyaluronic acid 0.3 Pantothenyl ethyl ether 5.0 Cepharanthin 0.05 Dipropylene glycol 1.0 POE (24 mol) · POP (13 mol) decyltetradecyl ether 0.5 lactic acid proper amount sodium lactate proper amount fragrance and dye proper amount purified water residue Production method: Dissolve acetylated hyaluronic acid in 95% ethanol, pantothenyl ethyl ether, cepharanthin, dipropylene glycol , POE (24mol) ・ POP (13mol)
Tetrasyltetradecyl ether and perfume were dissolved. Next, lactic acid, sodium lactate and a dye were dissolved in purified water, added to the ethanol part, and stirred to obtain a transparent liquid lotion.
【0035】 「実施例14:ローション」 配合成分 重量% 95%エタノール 60.0 アセチル化ヒアルロン酸 3.0 モノニトログアヤコールナトリウム 1.0 ビタミンB6 0.5 6−ベンジルアミノプリン 0.5 ジイソプロピルアミンジクロル酢酸 0.05 ポリエチレングリコール−400 1.0 POE硬化ヒマシ油(20モル) 1.0 リン酸 適量 香料および色素 適量 精製水 残分 製造方法:95%エタノールにアセチル化ヒアルロン酸
を溶解させ、モノニトログアヤコールナトリウム、ビタ
ミンB6、6−ベンジルアミノプリン、ジイソプロピル
アミンジクロル酢酸、ポリエチレングリコール−40
0、POE硬化ヒマシ油(20モル)、香料を溶解させ
た。次に、精製水にリン酸、色素を溶解させ、エタノー
ル部に加えた後、撹拌させ透明液状のローションを得
た。Example 14: Lotion Ingredients Weight% 95% Ethanol 60.0 Acetylated Hyaluronic Acid 3.0 Mononitroguaiacol Sodium 1.0 Vitamin B 6 0.5 6-Benzylaminopurine 0.5 Diisopropylamine Dichloroacetic acid 0.05 Polyethylene glycol-400 1.0 POE hydrogenated castor oil (20 mol) 1.0 Phosphoric acid Appropriate amount Flavor and pigment Appropriate amount Purified water residue Production method: Dissolve acetylated hyaluronic acid in 95% ethanol, mononitroguayacol sodium, vitamin B 6, 6- benzylaminopurine, diisopropylamine di chloroacetic acid, polyethylene glycol -40
0, POE hydrogenated castor oil (20 mol) and perfume were dissolved. Next, phosphoric acid and a dye were dissolved in purified water and added to the ethanol part, followed by stirring to obtain a transparent liquid lotion.
【0036】[0036]
【発明の効果】本発明によれば、優れた脱毛防止効果を
有し、さらにはフケ・カユミ防止効果にも優れている頭
皮頭髪用組成物を提供できる。According to the present invention, it is possible to provide a composition for scalp hair which has an excellent effect of preventing hair loss and also an excellent effect of preventing dandruff and Kayumi.
Claims (5)
を含有することを特徴とする頭皮頭髪用組成物。1. A composition for scalp and hair, comprising acetylated hyaluronic acid and a hair follicle activator.
基の置換数が、下記化学式「化1」で表される繰り返し
構造単位において平均して2〜4であることを特徴とす
る請求項1記載の頭皮頭髪用組成物。 【化1】 (式中、R1、R2、R3、R4は水素またはエステル結合
されたアセチル基を意味し、且つ平均して各繰り返し構
造においてR1〜R4の少なくとも2以上がアセチル基で
ある。R5は水素またはアルカリ金属原子を示す。)2. The acetylated hyaluronic acid according to claim 1, wherein the number of substitutions of the acetyl group in the repeating structural unit represented by the following chemical formula (Chemical Formula 1) is 2 to 4 on average. Composition for scalp hair. Embedded image (Wherein, R 1 , R 2 , R 3 , and R 4 each represent hydrogen or an acetyl group bonded through an ester bond, and on average, at least two or more of R 1 to R 4 in each repeating structure are acetyl groups. R 5 represents hydrogen or an alkali metal atom.)
タミンB6及びその誘導体、ビオチン、パントテン酸及
びその誘導体、セファランチン、モノニトログアヤコー
ル、モノニトログアヤコールナトリウム、6−ベンジル
アミノプリン、ジイソプロピルアミンジクロル酢酸、ヒ
ノキチオールからなる群から選ばれた一種または二種以
上であることを特徴とする請求項1または2記載の頭皮
頭髪用組成物。Wherein the hair follicle activating agent nicotinamide, vitamin of B 6 and derivatives thereof, biotin, pantothenic acid and its derivatives, cepharanthine, mononitroguayacol, mononitroguayacol sodium, 6-benzylaminopurine, diisopropylamine di The scalp hair composition according to claim 1 or 2, wherein the composition is one or more selected from the group consisting of chloroacetic acid and hinokitiol.
頭皮頭髪用組成物全量に対して0.001〜10重量%
であることを特徴とする請求項1、2または3記載の頭
皮頭髪用組成物。4. The content of the acetylated hyaluronic acid is 0.001 to 10% by weight based on the total amount of the scalp hair composition.
The composition for scalp hair according to claim 1, 2, or 3.
成物全量に対して0.001〜5重量%であることを特
徴とする請求項1、2、3または4記載の頭皮頭髪用組
成物。5. The scalp hair according to claim 1, wherein the content of the hair follicle activator is 0.001 to 5% by weight based on the total amount of the scalp hair composition. Composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP36340197A JPH11180833A (en) | 1997-12-16 | 1997-12-16 | Composition for scalp and hair |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP36340197A JPH11180833A (en) | 1997-12-16 | 1997-12-16 | Composition for scalp and hair |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11180833A true JPH11180833A (en) | 1999-07-06 |
Family
ID=18479222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP36340197A Withdrawn JPH11180833A (en) | 1997-12-16 | 1997-12-16 | Composition for scalp and hair |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH11180833A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005200357A (en) * | 2004-01-16 | 2005-07-28 | Kanebo Cosmetics Inc | Hair restoration |
JP2006513255A (en) * | 2002-10-30 | 2006-04-20 | アサト アクチェンゲゼルシャフト アプライド サイエンス アンド テクノロジー | Preparations containing melatonin, ginkgo and biotin |
JP2015519391A (en) * | 2012-06-15 | 2015-07-09 | ロレアル | Compositions, methods and uses comprising pyridine dicarboxylic acid esters and fixed polymers |
CN111329795A (en) * | 2020-04-02 | 2020-06-26 | 华熙生物科技股份有限公司 | Hair-blacking and hair-nourishing composition, application thereof and preparation method of hair-blacking and hair-nourishing product |
WO2025114962A1 (en) * | 2023-12-01 | 2025-06-05 | Shiseido Company, Ltd. | Cosmetic composition comprising acetylated hyaluronic acid |
-
1997
- 1997-12-16 JP JP36340197A patent/JPH11180833A/en not_active Withdrawn
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006513255A (en) * | 2002-10-30 | 2006-04-20 | アサト アクチェンゲゼルシャフト アプライド サイエンス アンド テクノロジー | Preparations containing melatonin, ginkgo and biotin |
JP2005200357A (en) * | 2004-01-16 | 2005-07-28 | Kanebo Cosmetics Inc | Hair restoration |
JP2015519391A (en) * | 2012-06-15 | 2015-07-09 | ロレアル | Compositions, methods and uses comprising pyridine dicarboxylic acid esters and fixed polymers |
CN111329795A (en) * | 2020-04-02 | 2020-06-26 | 华熙生物科技股份有限公司 | Hair-blacking and hair-nourishing composition, application thereof and preparation method of hair-blacking and hair-nourishing product |
CN111329795B (en) * | 2020-04-02 | 2023-03-21 | 华熙生物科技股份有限公司 | Hair-blacking and hair-nourishing composition, application thereof and preparation method of hair-blacking and hair-nourishing product |
WO2025114962A1 (en) * | 2023-12-01 | 2025-06-05 | Shiseido Company, Ltd. | Cosmetic composition comprising acetylated hyaluronic acid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2001288043A (en) | Composition for scalp and hair | |
JP2002173449A (en) | Hair-growing agent | |
WO1989002731A1 (en) | Hair tonic | |
JPH11180833A (en) | Composition for scalp and hair | |
JPH11236319A (en) | Composition for scalp and hair | |
JPH11180832A (en) | Composition for scalp and hair | |
JP4643789B2 (en) | Skin preparation | |
JP2001131031A (en) | Composition for scalp and hair | |
JPH11269043A (en) | Cosmetic for scalp and hair | |
JP2001288045A (en) | Composition for scalp and hair | |
JP2001288048A (en) | Composition for scalp and hair | |
JP2001288046A (en) | Composition for scalp and hair | |
JP2004315442A (en) | Gray hair-preventing/improving agent | |
JPH05301812A (en) | Skin external preparation | |
JP3483984B2 (en) | Cosmetics | |
JP2000026269A (en) | Cosmetic | |
JPH11302133A (en) | Cosmetic for scalp and hair | |
JPH08157337A (en) | Hair cosmetic | |
JP2000044436A (en) | Composition for scalp and hair treatment | |
JPH10147514A (en) | Cosmetic | |
JPH10273424A (en) | Cosmetic for hair | |
JPH07112966B2 (en) | Skin cosmetics | |
JP2001072567A (en) | Skin cosmetic | |
JPH11322545A (en) | Cosmetic for scalp and hair | |
JPH10273423A (en) | Cosmetic for hair |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20050301 |